Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background and purpose: The influence of metabolic syndrome (MetS) on cognitive and affective functions in patients with Alzheimer's disease (AD) was examined. Methods: A total of 570 AD patients were divided into two subgroups depending on waist circumference (WC) (normal versus achieving Japanese diagnostic criteria of MetS). Afterwards, the AD control subgroup was defined as those normal WC patients with no vascular risk factors (VRFs). The AD with MetS (AD-MetS) subgroup was defined as the MetS WC group who had two or more VRFs to qualify as having MetS. Cognitive and affective functions, insulin resistance, vascular endothelial function and white matter changes between AD-MetS and AD controls were compared. Results: Scores on the Mini-Mental State Examination, Hasegawa Dementia Score - Revised, Frontal Assessment Battery and Montreal Cognitive Assessment were worse in the AD-MetS group than in AD controls, but the difference was not significant. Some analyses were conducted twice, once including all patients and once including only late-elderly patients. Scores on the Geriatric Depression Scale were found to be significantly higher for AD-MetS than for AD controls (all ages, late-elderly), as were those for apathy (late-elderly). Furthermore, both the homeostasis model assessment of insulin resistance and reactive hyperemia index scores were significantly worse in AD-MetS than in AD controls, whilst white matter changes showed a tendency to be worse. Conclusions: Greater cognitive and affective decline occurs in patients with AD-MetS than in those without. Further, insulin resistance and vascular endothelial dysfunction are strongly correlated with AD-MetS before pathological white matter changes can be observed. Click here to view the accompanying paper in this issue.

Original languageEnglish
Pages (from-to)339-345
Number of pages7
JournalEuropean Journal of Neurology
Volume23
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Cognition
Alzheimer Disease
Waist Circumference
Insulin Resistance
Blood Vessels
Apathy
Metabolic Diseases
Hyperemia
Geriatrics
Dementia
Homeostasis
Depression

Keywords

  • Alzheimer's disease
  • Cognitive/affective functions
  • Insulin resistance
  • Metabolic syndrome
  • Vascular endothelial function
  • Vascular risk factors

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome. / Hishikawa, Nozomi; Fukui, Y.; Sato, Kota; Kono, S.; Yamashita, Toru; Ohta, Yasuyuki; Deguchi, K.; Abe, Koji.

In: European Journal of Neurology, Vol. 23, No. 2, 01.02.2016, p. 339-345.

Research output: Contribution to journalArticle

@article{e00a2357d084406b8969a100546a79e8,
title = "Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome",
abstract = "Background and purpose: The influence of metabolic syndrome (MetS) on cognitive and affective functions in patients with Alzheimer's disease (AD) was examined. Methods: A total of 570 AD patients were divided into two subgroups depending on waist circumference (WC) (normal versus achieving Japanese diagnostic criteria of MetS). Afterwards, the AD control subgroup was defined as those normal WC patients with no vascular risk factors (VRFs). The AD with MetS (AD-MetS) subgroup was defined as the MetS WC group who had two or more VRFs to qualify as having MetS. Cognitive and affective functions, insulin resistance, vascular endothelial function and white matter changes between AD-MetS and AD controls were compared. Results: Scores on the Mini-Mental State Examination, Hasegawa Dementia Score - Revised, Frontal Assessment Battery and Montreal Cognitive Assessment were worse in the AD-MetS group than in AD controls, but the difference was not significant. Some analyses were conducted twice, once including all patients and once including only late-elderly patients. Scores on the Geriatric Depression Scale were found to be significantly higher for AD-MetS than for AD controls (all ages, late-elderly), as were those for apathy (late-elderly). Furthermore, both the homeostasis model assessment of insulin resistance and reactive hyperemia index scores were significantly worse in AD-MetS than in AD controls, whilst white matter changes showed a tendency to be worse. Conclusions: Greater cognitive and affective decline occurs in patients with AD-MetS than in those without. Further, insulin resistance and vascular endothelial dysfunction are strongly correlated with AD-MetS before pathological white matter changes can be observed. Click here to view the accompanying paper in this issue.",
keywords = "Alzheimer's disease, Cognitive/affective functions, Insulin resistance, Metabolic syndrome, Vascular endothelial function, Vascular risk factors",
author = "Nozomi Hishikawa and Y. Fukui and Kota Sato and S. Kono and Toru Yamashita and Yasuyuki Ohta and K. Deguchi and Koji Abe",
year = "2016",
month = "2",
day = "1",
doi = "10.1111/ene.12845",
language = "English",
volume = "23",
pages = "339--345",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome

AU - Hishikawa, Nozomi

AU - Fukui, Y.

AU - Sato, Kota

AU - Kono, S.

AU - Yamashita, Toru

AU - Ohta, Yasuyuki

AU - Deguchi, K.

AU - Abe, Koji

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Background and purpose: The influence of metabolic syndrome (MetS) on cognitive and affective functions in patients with Alzheimer's disease (AD) was examined. Methods: A total of 570 AD patients were divided into two subgroups depending on waist circumference (WC) (normal versus achieving Japanese diagnostic criteria of MetS). Afterwards, the AD control subgroup was defined as those normal WC patients with no vascular risk factors (VRFs). The AD with MetS (AD-MetS) subgroup was defined as the MetS WC group who had two or more VRFs to qualify as having MetS. Cognitive and affective functions, insulin resistance, vascular endothelial function and white matter changes between AD-MetS and AD controls were compared. Results: Scores on the Mini-Mental State Examination, Hasegawa Dementia Score - Revised, Frontal Assessment Battery and Montreal Cognitive Assessment were worse in the AD-MetS group than in AD controls, but the difference was not significant. Some analyses were conducted twice, once including all patients and once including only late-elderly patients. Scores on the Geriatric Depression Scale were found to be significantly higher for AD-MetS than for AD controls (all ages, late-elderly), as were those for apathy (late-elderly). Furthermore, both the homeostasis model assessment of insulin resistance and reactive hyperemia index scores were significantly worse in AD-MetS than in AD controls, whilst white matter changes showed a tendency to be worse. Conclusions: Greater cognitive and affective decline occurs in patients with AD-MetS than in those without. Further, insulin resistance and vascular endothelial dysfunction are strongly correlated with AD-MetS before pathological white matter changes can be observed. Click here to view the accompanying paper in this issue.

AB - Background and purpose: The influence of metabolic syndrome (MetS) on cognitive and affective functions in patients with Alzheimer's disease (AD) was examined. Methods: A total of 570 AD patients were divided into two subgroups depending on waist circumference (WC) (normal versus achieving Japanese diagnostic criteria of MetS). Afterwards, the AD control subgroup was defined as those normal WC patients with no vascular risk factors (VRFs). The AD with MetS (AD-MetS) subgroup was defined as the MetS WC group who had two or more VRFs to qualify as having MetS. Cognitive and affective functions, insulin resistance, vascular endothelial function and white matter changes between AD-MetS and AD controls were compared. Results: Scores on the Mini-Mental State Examination, Hasegawa Dementia Score - Revised, Frontal Assessment Battery and Montreal Cognitive Assessment were worse in the AD-MetS group than in AD controls, but the difference was not significant. Some analyses were conducted twice, once including all patients and once including only late-elderly patients. Scores on the Geriatric Depression Scale were found to be significantly higher for AD-MetS than for AD controls (all ages, late-elderly), as were those for apathy (late-elderly). Furthermore, both the homeostasis model assessment of insulin resistance and reactive hyperemia index scores were significantly worse in AD-MetS than in AD controls, whilst white matter changes showed a tendency to be worse. Conclusions: Greater cognitive and affective decline occurs in patients with AD-MetS than in those without. Further, insulin resistance and vascular endothelial dysfunction are strongly correlated with AD-MetS before pathological white matter changes can be observed. Click here to view the accompanying paper in this issue.

KW - Alzheimer's disease

KW - Cognitive/affective functions

KW - Insulin resistance

KW - Metabolic syndrome

KW - Vascular endothelial function

KW - Vascular risk factors

UR - http://www.scopus.com/inward/record.url?scp=84956572611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956572611&partnerID=8YFLogxK

U2 - 10.1111/ene.12845

DO - 10.1111/ene.12845

M3 - Article

VL - 23

SP - 339

EP - 345

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 2

ER -